Study design and patients
melanoma, Cancer
MELANOMA, CANCER
CAPRA was a phase 1b, multicenter, open-label, single-arm study. Eligible patients were ≥ 18 years old and had histologically confirmed metastatic or unresectable stage IIIB to IV melanoma, according to the American Joint Committee on Cancer 7th edition [